Clinical trial
Aricept to Improve Functional Tasks in Vascular Dementia
NCT00457769 · Kessler Foundation, Other · Unknown status
Key facts
| NCT number | NCT00457769 |
|---|---|
| Title | Aricept to Improve Functional Tasks in Vascular Dementia |
| Official title | Phase 1 Study of Aricept Plus a Behavioral Strategy to Improve Functional Tasks in Vascular Dementia |
| Lead sponsor | Kessler Foundation, Other |
| Collaborators | Pfizer Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Stroke, Vascular Dementia, Memory Deficits |
| Intervention type | Drug |
| Interventions | Donepezil and self-generated memory training, Donepezil and experimenter-administered memory training |
| Enrollment | 18 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2021 |
| Completion | Dec 1, 2021 |
| First posted | Apr 6, 2007 |
| Last update posted | Feb 17, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: